DRKS00023364
Recruiting
Not Applicable
Seroprevalence of SARS CoV-2 infections/Covid-19 in blood donors and patients of the University Hospitals in Leipzig
Institut für Medizinische Mikrobiologie und Virologie, Universitätsklinikum Leipzig0 sites2,000 target enrollmentOctober 19, 2020
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- U07.1
- Sponsor
- Institut für Medizinische Mikrobiologie und Virologie, Universitätsklinikum Leipzig
- Enrollment
- 2000
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Four groups of individuals:
- •1\. All patients at the University Hospital from which blood has been taken for medical reasons
- •2\. Blood donors
- •3\. Patients from the neurologic walk\-in clinic
- •4\. Patients with advanced liver disease
Exclusion Criteria
- •Serum and plasma samples that are not suitable for technical reasons
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Seroprevalence of COVID 19 in childreHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/09/028040CTMRF KKCTH468
Active, not recruiting
Not Applicable
Prevalence of COVID19 antibodies among blood donors.CTRI/2021/01/030455ivetha M
Completed
Not Applicable
Corona Immunitas: a nationwide program of antibody studies of SARS-CoV-2 in the Swiss populatioISRCTN18181860Swiss School of Public Health28,000
Recruiting
Not Applicable
Seroprevalence of anti-SARS-CoV-2 antibody in response to COVID-19 vaccine in patients with i nflammatory bowel diseaseKCT0006901Keimyung University Dongsan Hospital150
Completed
Not Applicable
Seroprevalence of SARS-CoV-2 antibodies among healthcare workers with differing risk of exposureCOVID-1910047438NL-OMON49447niversitair Medisch Centrum Groningen600